Benitec Biopharma Limited advised that Dr. Craig Lewis has agreed to serve as Chief Medical Adviser (part-time) on the company's non-small cell lung cancer (NSCLC) program. Dr. Lewis is medical oncologist at Prince of Wales Hospital.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.31 USD | -1.06% | -2.42% | +186.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+186.71% | 79.98M | |
+67.42% | 62.86B | |
-0.92% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.16% | 26.46B | |
-22.85% | 18.9B | |
+4.68% | 12.67B | |
+23.45% | 12.27B | |
+28.20% | 12.07B |
- Stock Market
- Equities
- BNTC Stock
- News Benitec Biopharma Inc.
- Benitec Biopharma Limited Appoints Craig Lewis as Chief Medical Adviser